Takeda sets up deal to distribute Moderna’s COVID-19 vaccine in Japan
Takeda positions itself to distribute 40 million doses of Moderna’s COVID-19 vaccine in Japan starting next year.
Takeda positions itself to distribute 40 million doses of Moderna’s COVID-19 vaccine in Japan starting next year.
Sinovac increases second quarter R&D spending by 130% in race to bring COVID-19 vaccine to market.
Mesoblast plans “rapid scale-up in manufacturing” to meet anticipated demand for COVID-19 cell therapy.